People who are suffering from the MS condition do have some hope. Treatments for the Multiple Sclerosis condition have been developed after many different years of research. There are plenty of treatment options especially those designed to reduce the number of attacks in Relapsing Remitting MS. There are also treatments that can help manage symptoms and slow down the progression of the illness. Patients who are diagnosed with Relapsing Remitting MS can experience episodes of remissions and relapses. These remissions can last as long as decades but can also be as short as a month. Doctors do not know why some patients have longer remissions than others. Most people who have MS can fully recover from the symptoms of their disease during a remission.

The reason why a relapse occurs is that the immune system itself attacks and damages the outer covering of the nerve cells of the brain and the spinal cord. This protective covering enables the nerve cells to communicate signals between the brain and the body. A relapse or an exacerbation of the disease is caused when a new inflammation damages the nerve cells. There are many symptoms that can be associated with these inflammations and these symptoms are usually treated by a number of mediations. The relapse itself is usually treated by corticosteroids. MS drugs reduce the inflammation in question and reduce the length of the relapse.

MS can be helped and managed by using medications to slow the progression of the disease, particularly the Relapsing Remitting Multiple Sclerosis. The aim is to prevent the loss of mobility as long as possible. Some of these drugs are mitoxantrone, natalizumab, and interferon, as well as galtiramer acetate and interferon beta which are mostly used to reduce the number of relapses. There are also many medications which can help manage the symptoms of MS.

 

Treatment of RRMS

 

Multiple Sclerosis can cause acute attacks on these nerve cells. Attacks are managed with drugs called glucocorticoids. There are four types of injectable medications which are used to treat this disease, and particularly RRMS. These types are interferon beta-1a, interferon beta-1b, glatiramer acetate, and natalizumab. These four medications are used to prevent the disease from progressing. Another type of medication is Fingolimod and this it is administered orally.

These medications help with the MS condition of patients. Along with reducing the level of disability experienced by patients with a Multiple Sclerosis condition, these medications also lower the rate of relapse and the number of lesions created on the brain and spinal cord. New research is always being conducted to find new ways to stop remitting relapsing MS from advancing into a different and more dangerous stage of this illness. A cure is hopefully going to be found soon.